Abstract
Major depressive disorder (MDD) in college students is associated with substantial burden.
AIMS:
To assess 1-year incidence of MDD among incoming freshmen and predictors of MDD-incidence in a representative sample of students.
METHOD:
Prospective cohort study of first-year college students (baseline: n = 2,519, 1-year follow-up: n = 958) RESULTS: The incidence of MDD within the first year of college was 6.9% (SE = 0.8). The most important individual-level predictors of onset were prior suicide plans and/or attempts (OR = 9.5). The strongest population-level baseline predictors were history of childhood-adolescent trauma, stressful experience in the past 12 months, parental psychopathology, and other 12-month mental disorder. Multivariate cross-validated prediction (cross-validated AUC = 0.73) suggest that 36.1% of incident MDD cases in a replication sample would occur among the 10% of students at highest predicted risk (24.5% predicted incidence in this highest-risk subgroup).
CONCLUSIONS:
Screening at college entrance is a promising strategy to identify students at risk of MDD onset, which may improve the development and deployment of targeted preventive interventions.
| Original language | English |
|---|---|
| Pages (from-to) | 294-304 |
| Number of pages | 11 |
| Journal | Depression and Anxiety |
| Volume | 36 |
| Issue number | 4 |
| Early online date | 6 Dec 2018 |
| DOIs | |
| Publication status | Published - Apr 2019 |
Bibliographical note
FOCUS ON: DEPRESSION DIVERSITY IN TIME AND PLACEFunding
The Leuven College Survey was carried out in conjunction with the World Health Organization World Mental Health (WMH) survey initiative and is a part of the World Mental Health International College Student project. The WMH survey is supported by the National Institute of Mental Health (NIMH; R01MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, GlaxoSmithKline, and Bristol-Myers Squibb. A complete list of all within-country and cross-national WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/. In Belgium specifically, these activities were supported by the Belgian Fund for Scientific Research (11N0514N/11N0516N/1114717N), the King Baudouin Foundation (2014-J2140150-102905), and Eli Lilly (IIT-H6U-BX-I002). In Germany, the preparation of this paper was funded by BARMER.
| Funders | Funder number |
|---|---|
| Pfizer Foundation | |
| Pan American Health Organization | |
| World Health Organization World Mental Health | |
| BARMER | |
| GlaxoSmithKline | |
| John D. and Catherine T. MacArthur Foundation | |
| Ortho-McNeil Pharmaceutical | |
| National Institute of Mental Health | R13MH066849, R01MH069864, R01MH070884 |
| U.S. Public Health Service | R01 DA016558, R13-MH066849, R01-MH069864 |
| Koning Boudewijnstichting | 2014-J2140150-102905 |
| Belgian Fund for Scientific Research | 11N0514N/11N0516N/1114717N |
| Eli Lilly and Company | IIT-H6U-BX-I002 |
| Fogarty International Center | R03TW006481 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- depression
- epidemiology
- health services
- mood disorders
- suicide/self-harm
Fingerprint
Dive into the research topics of 'Prediction of major depressive disorder onset in college students'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver